TIRmed Pharma

Developing new treatments for eczema and virus

  • CEO: Anna-Lena Spetz
  • First investment year: 2020
  • Fund: Stockholm
  • Business sector: Life Science
TIRmed Pharma

TIRmed Pharma develops drug candidates addressing major clinical needs. One is a cream for the treatment of eczema and the other a nasal spray for viral respiratory infections, such as influenza, RS virus and Corona.